Skip to main content
Log in

Measuring the performance of quality assurance processes: pharmaceutical industry deviation management case study

  • Practitioner's Report
  • Published:
Accreditation and Quality Assurance Aims and scope Submit manuscript

Abstract

This article presents experience from the practice of a successful pharmaceutical company related to design and implementation of performance measures (PMs) for deviation management linked to the analysis of impact on the production cost for the selected product. Case study focuses on PMs within good manufacturing practice (GMP) processes related to quality assurance (QA) and quality management, with the aim of complying with its future requirements proposed by the European Commission. Critical areas were identified based on data gathered from the industrial deviation database. Implementation of the suggested corrective actions showed significant improvement in terms of reducing their number for more than 50% per selected deviation category. The results obtained in the course of this practice-oriented study contribute to further improvement of deviation management in the pharmaceutical industry and performance measurement of other GMP processes. The suggested performance measurement concept and problem-solving techniques may serve both practitioners and the decision-makers within QA and quality control (QC) in order to improve their processes by implementing relevant regulatory requirements for quality management and maintain compliance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Geijo F (2000) Quality management in analytical R&D in the pharmaceutical industry: building quality from GLP. Accred Qual Assur 5:16–20

    Article  Google Scholar 

  2. Kovac G, Porubenova A (2008) Evaluation of the quality of clinical laboratories in the Slovak, Republic: conceptual and contextual remarks. Accred Qual Assur 13:165–171

    Article  Google Scholar 

  3. Krouwer JS (2006) Dynamic rather than static performance measures are needed to improve patient safety. Accred Qual Assur 11:644–646

    Article  CAS  Google Scholar 

  4. Pohl B, Simon S, Kramer P-J (2008) Current experiences with a quality management system for non-clinical research and development in pharmaceutical industry. Accred Qual Assur 13:511–521

    Article  Google Scholar 

  5. Fabregas-Fernandez A, Garcia-Montoya E, Perez-Lozano P, Sune-Negre JM, Tico JR, Minarro M (2009) Quality assurance in research: incorporating ISO 9001:2000 into a GMP quality management system in a pharmaceutical R+D+I center. Accred Qual Assur. Published online: 10 Nov 2009

  6. Schmidt P (1999) Integrating accreditation, good laboratory practice and good manufacturing practice in an industrial analytical laboratory. Accred Qual Assur 4:129–132

    Article  Google Scholar 

  7. Bonk-Kassner C, Ehmann J, Gallhoff G, Moore DS, Moos B, Siegemund B (1997) Integration of parallel-operating quality systems. Accred Qual Assur 2:285–293

    Article  CAS  Google Scholar 

  8. Ehrmeyer SS, Laessig RH (2008) Can auditing save us from a quality disaster? Accred Qual Assur 13:139–144

    Article  Google Scholar 

  9. GMP Part I (2008) Basic requirements for medicinal products

  10. Saeed Arayne M, Najma S, Kamran Zaman M (2008) Historical incidents leading to the evolution of good manufacturing practice. Accred Qual Assur 13:431–432

    Article  Google Scholar 

  11. ISO 9001:(2008) Quality management systems—requirements

  12. EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use Part I—Draft (2009) http://ec.europa.eu/enterprise/newsroom/cf/document.cfm?action=display&doc_id=5587&userservice_id=1. Accessed 16 Feb 2010

  13. Parmenter D (2007) Key performance indicators (KPI): developing, implementing and using winning KPIs. Wiley, London

    Google Scholar 

  14. Nunnally BK, McConnell JS (2007) Six sigma in the pharmaceutical industry. CRC Press, Cleveland

    Google Scholar 

  15. McGurk TL, Snee RD (2005) A systematic approach to deviation reduction through six Sigma. Pharm Technol Sourc Manag 7:4–18

    Google Scholar 

  16. Neely A, Richards H, Mills J, Platts K, Bourne M (1997) Designing performance measures: a structured approach. Int J Oper Prod Manag 17:1131–1152

    Article  Google Scholar 

Download references

Acknowledgments

The authors are grateful to Hemofarm, Serbia and the Ministry of Science and Technological Development of the Republic of Serbia for the support (project TR 21006 and 34009).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zorana Boltic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boltic, Z., Ruzic, N., Jovanovic, M. et al. Measuring the performance of quality assurance processes: pharmaceutical industry deviation management case study. Accred Qual Assur 15, 629–636 (2010). https://doi.org/10.1007/s00769-010-0709-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00769-010-0709-2

Keywords

Navigation